Depends on the pharmaceutical. If you think .1% of extra cbd is going to be potentially life threatening then i dont think you understand this type of medicine.
you cant seriously be comparing those 3 companies with althea. We have a market cap of $130 million whereas those 3 major biotech companies have a combined $465 billion market cap.
however i do agree with you that althea has to be better with the consistency of their medicine and i have faith in the bod that they will make the necessary adjustments.
Ann: CBD Products to Become Available Over the Counter, page-51
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.23M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 510 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 109035 | 2 |
View Market Depth
| Last trade - 10.02am 08/11/2024 (20 minute delay) ? |
| AGH (ASX) Chart |
Day chart unavailable